Institutional
BOONE CAPITAL MANAGEMENT LLC
CIK 0001882053
$326.4M
Reported AUM
13
Positions
Q1 2026
Period
2026-05-15
Filed
The Brief · BOONE CAPITAL MANAGEMENT LLC · Q1 2026
AI · grounded in 13F
BOONE CAPITAL MANAGEMENT LLC established a new position in TFX valued at $33.3M. The fund also opened new stakes in GRDN for $23.8M and ASTRAZENECA PLC for $21.7M. On the sell side, the manager closed its position in NBIX, reducing exposure by $21.5M. Additional exits included HQY and RAPT.
Portfolio · Q1 2026
Top holdings
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MIRM | MIRUM PHARMACEUTICALS INC | $108.50 | -3.63% | 108.58% | 567.72% | $38.9M | 11.92% | — | HELD |
| 2 | IONS | IONIS PHARMACEUTICALS INC | $51.74 | -2.90% | 20.59% | 30.51% | $37.6M | 11.51% | — | HELD |
| 3 | CI | THE CIGNA GROUP | $284.05 | -1.25% | 12.13% | 49.02% | $36.7M | 11.24% | — | HELD |
| 4 | MDT | MEDTRONIC PLC | $84.23 | -1.73% | -2.60% | -26.16% | $34.5M | 10.57% | — | HELD |
| 5 | TFX | TELEFLEX INCORPORATED | $131.81 | -0.37% | 15.04% | -65.48% | $33.3M | 10.22% | — | HELD |
| 6 | BMRN | BIOMARIN PHARMACEUTICAL INC | $59.42 | -1.92% | 2.19% | -29.44% | $30.9M | 9.48% | — | HELD |
| 7 | GRDN | GUARDIAN PHARMACY SVCS INC | $39.69 | -3.67% | 95.23% | 121.61% | $23.8M | 7.28% | — | HELD |
| 8 | AZN | ASTRAZENECA PLC | $169.27 | -1.21% | 17.87% | 62.01% | $21.7M | 6.65% | — | HELD |
| 9 | UNH | UNITEDHEALTH GROUP INC | $419.72 | -0.42% | 80.64% | 9.66% | $21.4M | 6.57% | — | HELD |
| 10 | BBIO | BRIDGEBIO PHARMA INC | $79.71 | -2.96% | 72.55% | 63.11% | $17.0M | 5.21% | — | HELD |
| 11 | AVNS | AVANOS MED INC | — | — | 127.60% | -24.27% | $16.6M | 5.09% | — | HELD |
| 12 | KOD | KODIAK SCIENCES INC | $41.27 | -2.89% | 539.10% | -54.87% | $10.7M | 3.29% | — | HELD |
| 13 | TENX | TENAX THERAPEUTICS INC | $14.62 | -3.18% | 142.77% | -99.41% | $3.2M | 0.98% | — | HELD |
Source: SEC EDGAR · accession 0001214659-26-006448. 13F discloses long positions only — shorts, foreign equities, and options are excluded.